These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

868 related items for PubMed ID: 33769850

  • 1. Cost-effectiveness of oral semaglutide added to current antihyperglycemic treatment for type 2 diabetes.
    Guzauskas GF, Rind DM, Fazioli K, Chapman RH, Pearson SD, Hansen RN.
    J Manag Care Spec Pharm; 2021 Apr; 27(4):455-468. PubMed ID: 33769850
    [Abstract] [Full Text] [Related]

  • 2. Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis.
    Bloudek LM, Pandey R, Fazioli K, Ollendorf DA, Carlson JJ.
    J Manag Care Spec Pharm; 2021 Aug; 27(8):1046-1055. PubMed ID: 34337994
    [Abstract] [Full Text] [Related]

  • 3. The Effectiveness and Value of Oral Semaglutide for Type 2 Diabetes Mellitus.
    Fazioli KT, Rind DM, Guzauskas GF, Hansen RN, Pearson SD.
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1072-1076. PubMed ID: 32857658
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis.
    Pandey R, Ollendorf DA, Fazioli K, Bloudek L, Carlson JJ, Pearson SD.
    J Manag Care Spec Pharm; 2021 Mar; 27(3):405-410. PubMed ID: 33645245
    [Abstract] [Full Text] [Related]

  • 9. The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitors.
    Agboola F, Rind DM, Walton SM, Herron-Smith S, Quach D, Pearson SD.
    J Manag Care Spec Pharm; 2021 May; 27(5):667-673. PubMed ID: 33908280
    [Abstract] [Full Text] [Related]

  • 10. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value.
    Beinfeld M, Wasfy JH, Walton S, Sarker J, Nhan E, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2022 Mar; 28(3):369-375. PubMed ID: 35199575
    [Abstract] [Full Text] [Related]

  • 11. The Effectiveness and Value of Rivaroxaban and Icosapent Ethyl as Additive Therapies for Cardiovascular Disease.
    Synnott PG, McQueen RB, Ollendorf DA, Campbell JD, Pearson SD.
    J Manag Care Spec Pharm; 2020 Jun; 26(6):782-785. PubMed ID: 32463783
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review's Midwest Comparative Effectiveness Public Advisory Council.
    Nikitin D, Makam AN, Suh K, McKenna A, Carlson JJ, Richardson M, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2023 Feb; 29(2):216-221. PubMed ID: 36705279
    [Abstract] [Full Text] [Related]

  • 14. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value.
    Agboola F, Atlas SJ, Brouwer E, Carlson JJ, Hansen RN, Herron-Smith S, Nhan E, Rind DM, Pearson SD.
    J Manag Care Spec Pharm; 2022 Jan; 28(1):108-114. PubMed ID: 34949111
    [Abstract] [Full Text] [Related]

  • 15. Assessing the Value of Sarilumab Monotherapy for Adults with Moderately to Severely Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.
    Whittington MD, McQueen RB, Ollendorf DA, Chapman RH, Kumar VM, Synnott PG, Agboola F, Campbell JD.
    J Manag Care Spec Pharm; 2019 Jan; 25(1):80-87. PubMed ID: 30589626
    [Abstract] [Full Text] [Related]

  • 16. The effectiveness and value of bempedoic acid and inclisiran for heterozygous familial hypercholesterolemia and secondary prevention of ASCVD.
    Agboola F, Lin GA, Kazi DS, McKenna A, Pearson SD.
    J Manag Care Spec Pharm; 2021 Jul; 27(7):961-966. PubMed ID: 34185561
    [Abstract] [Full Text] [Related]

  • 17. The effectiveness and value of eculizumab and efgartigimod for generalized myasthenia gravis.
    Tice JA, Touchette DR, Lien PW, Agboola F, Nikitin D, Pearson SD.
    J Manag Care Spec Pharm; 2022 Jan; 28(1):119-124. PubMed ID: 34949112
    [Abstract] [Full Text] [Related]

  • 18. The Effectiveness and Value of Esketamine for the Management of Treatment-Resistant Depression.
    Agboola F, Atlas SJ, Touchette DR, Fazioli K, Pearson SD.
    J Manag Care Spec Pharm; 2020 Jan; 26(1):16-20. PubMed ID: 31880219
    [Abstract] [Full Text] [Related]

  • 19. Anti B-cell maturation antigen CAR T-cell and antibody drug conjugate therapy for heavily pretreated relapsed and refractory multiple myeloma.
    Beinfeld M, Lee S, McQueen B, Fluetsch N, Pearson SD, Ollendorf DA.
    J Manag Care Spec Pharm; 2021 Sep; 27(9):1315-1320. PubMed ID: 34464215
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of Drugs to Treat Relapsed/Refractory Multiple Myeloma in the United States.
    Carlson JJ, Guzauskas GF, Chapman RH, Synnott PG, Liu S, Russo ET, Pearson SD, Brouwer ED, Ollendorf DA.
    J Manag Care Spec Pharm; 2018 Jan; 24(1):29-38. PubMed ID: 29290170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.